User:Greenbear/sandbox

From 2008.igem.org

< User:Greenbear(Difference between revisions)
 
(6 intermediate revisions not shown)
Line 1: Line 1:
-
<!--- Banner --->
+
<div id="header">{{User:Greenbear/sandbox/header}}</div>
-
<div id="banner">
+
-
[[Image:Banner.jpg]]
+
-
</div>
+
-
<div id="body" style="background-color: #CCCCCC;">
+
<div id="maincontent" style="margin-top:200px;">
 +
=[[Team:NTU-Singapore/Team|Team background]]=
 +
{|
 +
|The NTU-Singapore iGEM08 team consists of six undergraduate students working full-time from May to July 2008 . In addition, we have a number of graduate students and faculty advisors.
-
<!--- Navigation bar --->
+
|[[Image:Example_logo.png|200px|right|frame]]
-
<div id="nav">
+
-
{| style="color:#1b2c8a;background-color:#CCCC99;" cellpadding="5" cellspacing="0" border="1" bordercolor="#fff" width="800px"
+
-
!align="center"|[[Team:NTU-Singapore|Home]]
+
-
!align="center"|[[Team:NTU-Singapore/Team|The Team]]
+
-
!align="center"|[[Team:NTU-Singapore/Project|The Project]]
+
-
!align="center"|[[Team:NTU-Singapore/Parts|Parts Submitted to the Registry]]
+
-
!align="center"|[[Team:NTU-Singapore/Modeling|Modeling]]
+
-
!align="center"|[[Team:NTU-Singapore/Notebook|Notebook]]
+
-
!align="center"|[[Team:NTU-Singapore/Acknowledgements|Acknowledgements]]
+
|}
|}
-
</div>
 
-
<!--- End of navigation bar --->
 
-
{|align="justify"
+
=[[Team:NTU-Singapore/Project|Project introduction]]=
-
|You can write a background of your team here. Give us a background of your team, the members, etc.  Or tell us more about something of your choosing.
+
{|
-
|[[Image:Example_logo.png|200px|right|frame]]
+
|Our group has decided to engineer E.coli as a carrier for ''colicin E7'' to deal with the pathogenic strain of Ecoli known as ''Escherichia coli O157:H7''.  
-
|-
+
Escherichia coli O157:H7 is an ''enterohemorrhagic strain'' that can cause bloody diarrhea and kidney failure. Current methods of cure for the infection include blood transfusion and dialysis. Currently no antibiotic is able to kill it.
-
|
+
 
-
''Tell us more about your project. Give us background. Use this is the abstract of your project.  Be descriptive but concise (1-2 paragraphs)''
+
Our approach is to use ''Colicin E7'' to kill the this harmful strain of bacteria. We intend to use our very own genetically engineered E.coli as the carrier of the colicin. We also wish for our bacteria to able to detect the presence of blood and the bacteria before it releases the colicins to eradicate the pathogen.
 +
 
 +
Our aim would be to control the level of colicin production in our bacteria. Our engineered bacteria should also be able to be accurate in its detection.
 +
 
 +
As an extension for our project, we can also investigate the dynamics of biological interactions,, i.e. mutualism, neutralism; using our engineered bacteria.
 +
 
 +
For any comments or enquiries, contact us at [mailto:ntu.igem@gmail.com ntu.igem@gmail.com]  
|[[Image:Team.png|right|frame|Your team picture]]
|[[Image:Team.png|right|frame|Your team picture]]
-
|-
 
-
|
 
-
|align="center"|[[Team:NTU-Singapore | Team Example 2]]
 
|}
|}
</div>
</div>
-
<!--- The Mission, Experiments --->
 

Latest revision as of 09:02, 25 May 2008

Team background

The NTU-Singapore iGEM08 team consists of six undergraduate students working full-time from May to July 2008 . In addition, we have a number of graduate students and faculty advisors.
Example logo.png

Project introduction

Our group has decided to engineer E.coli as a carrier for colicin E7 to deal with the pathogenic strain of Ecoli known as Escherichia coli O157:H7.

Escherichia coli O157:H7 is an enterohemorrhagic strain that can cause bloody diarrhea and kidney failure. Current methods of cure for the infection include blood transfusion and dialysis. Currently no antibiotic is able to kill it.

Our approach is to use Colicin E7 to kill the this harmful strain of bacteria. We intend to use our very own genetically engineered E.coli as the carrier of the colicin. We also wish for our bacteria to able to detect the presence of blood and the bacteria before it releases the colicins to eradicate the pathogen.

Our aim would be to control the level of colicin production in our bacteria. Our engineered bacteria should also be able to be accurate in its detection.

As an extension for our project, we can also investigate the dynamics of biological interactions,, i.e. mutualism, neutralism; using our engineered bacteria.

For any comments or enquiries, contact us at ntu.igem@gmail.com

Your team picture